These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21673581)

  • 41. Evolving public views on the value of one's DNA and expectations for genomic database governance: Results from a national survey.
    Briscoe F; Ajunwa I; Gaddis A; McCormick J
    PLoS One; 2020; 15(3):e0229044. PubMed ID: 32160204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study.
    Feehan M; Walsh M; Godin J; Sundwall D; Munger MA
    J Clin Pharm Ther; 2017 Dec; 42(6):738-749. PubMed ID: 28627110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attitudes on warfarin pharmacogenetic testing in Chinese patients and public.
    Chan SL; Low JJ; Chia KS; Wee HL
    Int J Technol Assess Health Care; 2014 Jan; 30(1):113-20. PubMed ID: 24468050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacogenetics in future medical care -- implications for patients and physicians].
    Rogausch A; Brockmöller J; Himmel W
    Gesundheitswesen; 2005 Apr; 67(4):257-63. PubMed ID: 15856385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.
    Haga SB; Liu Y
    Pharmacogenomics; 2019 Jun; 20(8):581-587. PubMed ID: 31190624
    [No Abstract]   [Full Text] [Related]  

  • 46. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a pharmacogenetic educational toolkit for community pharmacists.
    Haga SB; Mills R; Moaddeb J
    Pharmacogenomics; 2016 Sep; 17(14):1491-502. PubMed ID: 27533631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
    Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
    Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
    Haga SB; LaPointe NM; Cho A; Reed SD; Mills R; Moaddeb J; Ginsburg GS
    Pharmacogenomics; 2014 Sep; 15(13):1677-86. PubMed ID: 25410893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors influencing uptake of pharmacogenetic testing in a diverse patient population.
    O'Daniel J; Lucas J; Deverka P; Ermentrout D; Silvey G; Lobach DF; Haga SB
    Public Health Genomics; 2010; 13(1):48-54. PubMed ID: 19407441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Professional perspectives about pharmacogenetic testing and managing ancillary findings.
    Haga SB; Tindall G; O'Daniel JM
    Genet Test Mol Biomarkers; 2012 Jan; 16(1):21-4. PubMed ID: 21770772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Personalized medicine: is it a pharmacogenetic mirage?
    Shah RR; Shah DR
    Br J Clin Pharmacol; 2012 Oct; 74(4):698-721. PubMed ID: 22591598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
    Haga SB; Mills R; Moaddeb J; Allen LaPointe N; Cho A; Ginsburg GS
    Pharmacogenomics; 2017 Mar; 18(4):359-367. PubMed ID: 28244812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A survey of U.S. public perspectives on facial recognition technology and facial imaging data practices in health and research contexts.
    Katsanis SH; Claes P; Doerr M; Cook-Deegan R; Tenenbaum JD; Evans BJ; Lee MK; Anderton J; Weinberg SM; Wagner JK
    PLoS One; 2021; 16(10):e0257923. PubMed ID: 34648520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
    Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
    JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Community pharmacists, Internet and social media: an empirical investigation.
    Shcherbakova N; Shepherd M
    Res Social Adm Pharm; 2014; 10(6):e75-e85. PubMed ID: 24388002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The landscape of pharmacogenetic testing in a US managed care population.
    Anderson HD; Crooks KR; Kao DP; Aquilante CL
    Genet Med; 2020 Jul; 22(7):1247-1253. PubMed ID: 32291400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenetic testing: not as simple as it seems.
    Haga SB; Burke W
    Genet Med; 2008 Jun; 10(6):391-5. PubMed ID: 18496219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
    Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with Polypharmacy.
    Sugarman EA; Cullors A; Centeno J; Taylor D
    Drugs Aging; 2016 Dec; 33(12):929-936. PubMed ID: 27826798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.